-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Short Interest in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Declines By 11.6%
Short Interest in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Declines By 11.6%
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) was the recipient of a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 824,900 shares, a decrease of 11.6% from the November 15th total of 932,900 shares. Based on an average daily volume of 1,430,000 shares, the days-to-cover ratio is currently 0.6 days. Approximately 11.0% of the shares of the stock are sold short.
Bright Minds Biosciences Price Performance
Shares of Bright Minds Biosciences stock traded up $0.03 during trading on Monday, hitting $0.94. 1,304 shares of the stock traded hands, compared to its average volume of 3,375,314. The firm's fifty day moving average is $1.01 and its 200-day moving average is $1.14. Bright Minds Biosciences has a 52 week low of $0.75 and a 52 week high of $4.75.
Get Bright Minds Biosciences alerts:Hedge Funds Weigh In On Bright Minds Biosciences
An institutional investor recently bought a new position in Bright Minds Biosciences stock. Jane Street Group LLC purchased a new position in shares of Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm purchased 24,701 shares of the company's stock, valued at approximately $37,000. Jane Street Group LLC owned about 0.21% of Bright Minds Biosciences at the end of the most recent reporting period. Hedge funds and other institutional investors own 4.03% of the company's stock.
Bright Minds Biosciences Company Profile
(Get Rating)Bright Minds Biosciences Inc, a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry.
Read More
- Get a free copy of the StockNews.com research report on Bright Minds Biosciences (DRUG)
- Madrigal Pharmaceuticals Stock Is Up 200% In One Day, Here's Why
- Four Profitable RV Stocks To Ride Out Recession
- Can Boeing Stock Soar in 2023?
- How Do Chipmakers Stack Up When It Comes To Growth?
- Is AMC Entertainment Stock Worth Taking Down Here?
Receive News & Ratings for Bright Minds Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bright Minds Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) was the recipient of a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 824,900 shares, a decrease of 11.6% from the November 15th total of 932,900 shares. Based on an average daily volume of 1,430,000 shares, the days-to-cover ratio is currently 0.6 days. Approximately 11.0% of the shares of the stock are sold short.
光明之心生物科學公司(納斯達克:藥物獲取評級)是11月份空頭股數銷量大幅下降的接受者。截至11月30日,空頭股數共有82.49萬股,較11月15日的93.29萬股減少11.6%。根據日均成交量1,430,000股計算,目前天數與回補比率為0.6天。大約11.0%的股票被賣空。
Bright Minds Biosciences Price Performance
Bright Minds生物科學的價格表現
Shares of Bright Minds Biosciences stock traded up $0.03 during trading on Monday, hitting $0.94. 1,304 shares of the stock traded hands, compared to its average volume of 3,375,314. The firm's fifty day moving average is $1.01 and its 200-day moving average is $1.14. Bright Minds Biosciences has a 52 week low of $0.75 and a 52 week high of $4.75.
在週一的交易中,Bright Minds Biosciences的股價上漲了0.03美元,達到0.94美元。該股共有1,304股易手,而其平均成交量為3,375,314股。該公司的50日移動均線切入位為1.01美元,200日移動均線切入位為1.14美元。Bright Minds Biosciences的52周低點為0.75美元,52周高位為4.75美元。
Hedge Funds Weigh In On Bright Minds Biosciences
對沖基金對Bright Minds生物科學的看法
An institutional investor recently bought a new position in Bright Minds Biosciences stock. Jane Street Group LLC purchased a new position in shares of Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm purchased 24,701 shares of the company's stock, valued at approximately $37,000. Jane Street Group LLC owned about 0.21% of Bright Minds Biosciences at the end of the most recent reporting period. Hedge funds and other institutional investors own 4.03% of the company's stock.
一家機構投資者最近買入了Bright Minds Biosciences股票的新頭寸。建恩街集團(Jane Street Group LLC)提交給美國證券交易委員會的最新13F檔案顯示,該公司在第一季度購買了光明心靈生物科學公司(Bright Minds Biosciences Inc.)的新股票頭寸。該公司購買了24,701股該公司股票,價值約37,000美元。在最近一次報告期結束時,建恩街集團擁有Bright Minds Biosciences約0.21%的股份。對沖基金和其他機構投資者持有該公司4.03%的股份。
Bright Minds Biosciences Company Profile
Bright Minds生物科學公司簡介
Bright Minds Biosciences Inc, a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry.
Bright Minds Biosciences Inc是一家臨床前生物科學公司,開發5-羥色胺(5-HT)藥物,以改善嚴重和改變生活的疾病患者的生活。該公司的選擇性5-羥色胺受體激動劑組合包括5-HT2C、5-HT2A和5-HT2C/A,用於治療癲癇、疼痛和神經精神病學。
Read More
閱讀更多內容
- Get a free copy of the StockNews.com research report on Bright Minds Biosciences (DRUG)
- Madrigal Pharmaceuticals Stock Is Up 200% In One Day, Here's Why
- Four Profitable RV Stocks To Ride Out Recession
- Can Boeing Stock Soar in 2023?
- How Do Chipmakers Stack Up When It Comes To Growth?
- Is AMC Entertainment Stock Worth Taking Down Here?
- 免費獲取StockNews.com關於Bright Minds生物科學(藥物)的研究報告
- Madrigal製藥公司的股票在一天內上漲了200%,原因如下
- 四隻盈利的房車股安然度過經濟衰退
- 2023年波音股價會飆升嗎?
- 當談到增長時,晶片製造商是如何提升的?
- AMC娛樂股票值得在這裡下跌嗎?
Receive News & Ratings for Bright Minds Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bright Minds Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Bright Minds生物科學日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Bright Minds Biosciences和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧